Ultima Genomics
Published indications, not live orders. Newest first; matching records grouped.
Latest observed . Availability is not verified.
Buyers 0
No published buyers.
Sellers 5
| Date | Price / size | Broker | Terms |
|---|---|---|---|
| UnpricedSize undisclosed | Setter Capital | Not specifiedNotesListed as inventory from the past four days; terms not provided. | |
| UnpricedSize undisclosed | Setter Capital | Not specifiedNotesListed in the past four days of inventory; terms not provided. | |
| UnpricedSize undisclosed | Setter Capital | Not specifiedNotesListed under past four days of supply inventory. | |
| UnpricedSize undisclosed | Setter Capital | Not specifiedNotesListed in the past four days of inventory, indicating supply. | |
| UnpricedSize undisclosed | Setter Capital | Not specifiedNotesSupply available in the latest daily inventory. |
Financing history
| Round | Date | Raised | Pre-money | Post-money | Price / share | Investors |
|---|---|---|---|---|---|---|
| Series E | May 31, 2022 | $229.25M | $3.4B | $3.63B | $50.14 | aMoon Fund, Andreessen Horowitz +11
|
| Series D | Dec 22, 2021 | $150M | $1.25B | $1.4B | $21.77 | Khosla Ventures
|
| Grant | Jan 1, 2020 | — | — | — | — | — |
| Series A | Dec 28, 2017 | — | — | — | — | — |
| Series B | Undated | — | — | — | — | — |
| Series C | Undated | — | — | — | — | — |
| Later Stage VC | Undated | — | — | — | — | — |
| Seed Round | Undated | — | — | — | — | — |
PitchBook cached data. Investor participation is historical, not proof of current ownership. Lead labels appear only when reported. Missing details remain unspecified.
Investor participation · 13 names in the returned rounds
| Investor | Reported rounds |
|---|---|
| aMoon Fund | Series E · 2022-05-31 |
| Andreessen Horowitz | Series E · 2022-05-31 |
| Bow River Capital | Series E · 2022-05-31 |
| D1 Capital Partners | Series E · 2022-05-31 |
| Founders Fund | Series E · 2022-05-31 |
| General Atlantic Service | Series E · 2022-05-31 |
| Khosla Ventures | Series E · 2022-05-31 Series D · 2021-12-22 |
| Lightspeed Venture Partners | Series E · 2022-05-31 |
| Lightspeed Venture Partners Israel | Series E · 2022-05-31 |
| Marius Nacht | Series E · 2022-05-31 |
| Playground Global | Series E · 2022-05-31 |
| Potentum Partners | Series E · 2022-05-31 |
| Regeneron Pharmaceuticals | Series E · 2022-05-31 |
Cached deal details · 8 rounds
| Round / date | Type / status | Investors | Exiting investors | Stored on |
|---|---|---|---|---|
| Series E2022-05-31 | Later Stage VCCompleted | aMoon Fund, Andreessen Horowitz +11
| Not specified | 2026-10-16 |
| Series D2021-12-22 | Later Stage VCCompleted | Khosla Ventures
| Not specified | 2026-10-16 |
| Grant2020-01-01 | Not specifiedStatus not specified | — | Not specified | 2026-10-16 |
| Series A2017-12-28 | Not specifiedStatus not specified | — | Not specified | 2026-10-16 |
| Series BUndated | Not specifiedStatus not specified | — | Not specified | 2026-10-16 |
| Series CUndated | Not specifiedStatus not specified | — | Not specified | 2026-10-16 |
| Later Stage VCUndated | Not specifiedStatus not specified | — | Not specified | 2026-10-16 |
| Seed RoundUndated | Not specifiedStatus not specified | — | Not specified | 2026-10-16 |
Stored on is the local round-record date, not the last time PitchBook verified it. No new provider lookups run when this page is opened.
Share classes
| Series | Issue price | Liq. preference | Ownership | Shares authorized |
|---|---|---|---|---|
| Series E | $44.57 | — | 4.7% | 3,400,000 |
| Series E-1 | $50.14 | 1× | 2.14% | 3,600,000 |
| Series D | $21.77 | 1× | 9.67% | 7,000,000 |
| Series C | $11.76 | 1× | 14.43% | 10,446,733 |
| Series B | $5.03 | 1× | 15.35% | 11,109,630 |
| Series A | $3.24 | 1× | 13.48% | 9,759,520 |
| Seed | $1.78 | 1× | 9.89% | 7,157,895 |
Suggest a correction · Active members can send a private report for admin review.